Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Stroke|April 28, 2025
Association of Biomarkers With Intracerebral Hematoma Expansion and Arterial Thromboembolic Events in Patients With Acute Intracranial Hemorrhage: The ANNEXA-I Biomarker SubstudyJohn W Eikelboom, Mukul Sharma, Lizhen Xu, et al.
JAMA Neurology|July 10, 2021
Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical TrialYongjun Wang, Yuesong Pan, Hao Li, et al.
Neurology|April 19, 2022
Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic AttackYongjun Wang, Yuesong Pan, Hao Li, et al.
Research and Practice in Thrombosis and Haemostasis|October 27, 2025
Andexanet alfa for the reversal of the low-molecular-weight heparin enoxaparinThijs F van Haaps, Alexander P Benz, Lizhen Xu, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 17, 2019
Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trialJ Donald Easton, Hans Denison, Scott R Evans, et al.
Stroke|September 3, 2021
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic AttackS Claiborne Johnston, Pierre Amarenco, Maria Aunes, et al.
BMJ Neurology Open|August 28, 2023
Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trialAmarjeet Tank, S Claiborne Johnston, Ritika Jain, et al.
Clinical Trials (London, England)|July 16, 2020
Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trialScott R Evans, Mikael Knutsson, Pierre Amarenco, et al.
Brain and Behavior|April 29, 2024
Total intracranial hemorrhage volume measurement summating all compartments best in traumatic and nontraumatic intracranial bleedingMacKenzie Horn, Ankur Banerjee, Linda Kasickova, et al.
Stroke|February 20, 2019
Time to Loading Dose and Risk of Recurrent Events in the SOCRATES TrialCarlos A Molina, S Claiborne Johnston, Per Ladenvall, et al.
Pageof 4